• Thyroxine (T4), Total
  • Doxylamine, Urine
  • Acanthamoeba and Naegleria Culture and Stains, Corneal Scraping
  • Schistosoma, Antibody, IgG
  • Actin (Smooth Muscle) Antibody, IgG
  • Mucopolysaccharidosis VI (ARSB) Gene Mutation Analysis
  • Acid-Fast Bacillus (AFB) Stain, Other Specimen
  • Ganglioside (GM1, GD1b, and GQ1b) Antibody, IgG and IgM
  • Hepatitis B Virus (HBV) by Molecular Method, Qualitative
  • TGFBR1 Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.
Loading...